National Comprehensive Cancer Network

About NCCN

NCCN Participates in the MENA-NCCN Guideline Adaptation Workshop

By Jorge Bacigalupo, Global Business Development Specialist, NCCN

On 18 December 2015, the National Comprehensive Cancer Network® (NCCN®) leadership participated in the MENA-NCCN Guideline Adaptation Workshop held live from Riyadh, Saudi Arabia and via webinar from Fort Washington, Pennsylvania, United States. The workshop was organized and directed by the MENA-NCCN Committee, under the leadership of. Abdul Rahman Jazieh, MD, MPH, Chairman, Department of Oncology, King Abdulaziz Medical City – Riyadh. 

The 2015 workshop brought together physician leaders from different countries within the Middle East North Africa (MENA) region and served as a platform to educate and help guide physicians in the MENA region about the adaptation process of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®).

Joan S. McClure, MS, Senior Vice President of Clinical Information and Publications, NCCN, led a presentation titled, “NCCN-MENA.”  The purpose of the presentation was to highlight NCCN’s global initiatives and innovative derivatives product of the NCCN Guidelines®, such as the NCCN Resource Stratified Framework for the NCCN Guidelines (NCCN Framework™) and NCCN Guidelines with NCCN Evidence Blocks™, as well as to discuss the potential application of these products in the MENA region.

“This is a great initiative that creates access and accounts for regional differences. NCCN is proud to collaborate with the MENA-NCCN Committee,” said Ms. McClure at the conclusion of her presentation.

The global influence and demand for the NCCN Guidelines is ever-increasing. Today, nearly half of all registered users of the NCCN Guidelines on report that they live outside the United States. In order to increase the global access to high-quality, high-value cancer care, NCCN has developed strategic global initiatives. NCCN and MENA-NCCN are collaborating to develop regionally adapted versions of the NCCN Guidelines for Breast, Colon, Hepatobiliary, Non-Small Cell Lung, and Prostate Cancers as well as for Non-Hodgkin’s Lymphomas. NCCN regularly works with physician groups to adapt NCCN Guidelines to reflect genetic variations in metabolism of agents, regulatory environments of host countries, as well as access to resources.

For more information about NCCN global initiatives, please visit